Persbericht Biocartis Group NV: Biocartis’ Idylla™ SARS-CoV-2 testing detecteert met succes de omicron variant
09 déc. 2021 01h00 HE
|
Biocartis NV
PERSBERICHT: 9 december 2021, 07:00 CET Biocartis’ Idylla™ SARS-CoV-2 testing detecteert met succes de omicron variant Mechelen, België, 9 december 2021 – Biocartis Group NV (de ‘Vennootschap’...
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Full Product Registration Approval in Indonesia
08 déc. 2021 07h50 HE
|
Achiko AG
Second-generation of AptameX, Achiko’s innovative DNA aptamer diagnostic test for Covid-19 has received full approval in Indonesia for five yearsProduction of the second-generation AptameX kits to...
BioNTech gibt virtuelle Pressekonferenz zu Omikron-Variante
08 déc. 2021 07h15 HE
|
BioNTech SE
MAINZ, Deutschland, 8. Dezember 2021 – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Mittwoch, den 8. Dezember 2021, eine virtuelle Pressekonferenz abhalten, um die Ergebnisse...
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
08 déc. 2021 07h15 HE
|
BioNTech SE
MAINZ, Germany, December 8, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference on Wednesday, December 8, 2021, to present the results from initial...
Pfizer und BioNTech geben Update zur Omikron-Variante
08 déc. 2021 06h56 HE
|
BioNTech SE
Vorläufige Ergebnisse von Laboruntersuchungen zeigen, dass drei Impfdosen des Pfizer-BioNTech COVID-19-Impfstoffs die Omikron-Variante (B.1.1.529) neutralisieren, wohingegen zwei Impfdosen signifikant...
Pfizer and BioNTech Provide Update on Omicron Variant
08 déc. 2021 06h56 HE
|
BioNTech SE
Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage), while two doses show significantly reduced...
MAKO Medical Detects Three Cases of COVID-19 Omicron Variant in U.S.
07 déc. 2021 08h45 HE
|
MAKO Medical
Raleigh, North Carolina, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, today announced that it has detected three cases...
Vir Biotechnology to Host a Call on Sotrovimab’s Retained Activity Against the Omicron SARS-CoV-2 Variant
07 déc. 2021 03h55 HE
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) announced that Management will host a conference call at 8:30 am ET, Tuesday, December 7, 2021, to discuss new...
Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant
07 déc. 2021 03h48 HE
|
Vir Biotechnology, Inc.
– New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published last week, underscoring the...
iHealth Statement on the COVID-19 Omicron Variant and Its At-Home Test Kit's Effectiveness
02 déc. 2021 17h37 HE
|
iHealth Labs Inc
SUNNYVALE, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- iHealth Labs Inc., a leader in the design and manufacturing of consumer-friendly, mobile personal healthcare products, issued the following...